-
hcup-us.ahrq.gov/reports/methods/MS2021-03-NHQDRMethodsReport.pdf
December 09, 2021 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2021 National Healthcare Quality and Disparities Report (NHQDR)
HCUP Methods Series
Methods Applying AHRQ Quality Indicators to Healthcare Cost
and Utilization Project (HCUP) Data for the 2021 National
Healthcar…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment
Future Research Needs Paper
Number 9
Future Research Needs
for Attention Deficit
Hyperactivity Disorder:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 111
Allergen-Specific Immunotherapy for the Treatment
of Allergic Rhinoconjunctivitis and/or Asthma:
Comparative Effectiveness Review
Executive Summary
Background
Allergic rhinitis is a widespread
clinical problem, estimated to affect
20 to 40 percent of the popu…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparative Effectiveness Review
118
Appendix A. Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names
provided only for
drugs under
patent.)
Half-life or other
relevant
pharmacokinetic
feature
Labeled indications Dosing (oral
doses)
Dose adjustments fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
January 01, 2009 - 1
Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest, Continuously Enrolled Medicare Parts A
and B Fee-for-Service (FFS) Population, by Class of Drug and Active Ingredient, 2006-2009
Note: An asterisk (*) signifies a small cell count (less than 11).
Persons per 10…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
January 01, 2006 - 1
Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population)
by Class of Drug and Active Ingredient, 2006-2009
Note: A single period (.) signifies a small cell count (less than 11).
Use filters to rank by beneficiary count.
…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/continuing-ed/moc_sms.pdf
March 29, 2016 - Patient Self-Management Support: A Chronic Conditions Practice Improvement Activity
Advancing Excellence in Health Care–•–www.ahrq.gov
Patient SelfManagement Support
A Chronic Conditions Practice Improvement Activity
User Guide
Resources
To use a screen reader application with this module, please change your …
-
www.ahrq.gov/sites/default/files/publications/files/crctoolkit.pdf
December 01, 2010 - Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention
Toolkit for the System Approach to Tracking and Increasing
Screening for Public Health Improvement of Colorectal
Cancer Intervention
These materials enable implementation of the …
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/crctoolkit/crctoolkit.pdf
December 01, 2010 - Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention
Toolkit for the System Approach to Tracking and Increasing
Screening for Public Health Improvement of Colorectal
Cancer Intervention
These materials enable implementation of the …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third and final surveillance report for the Agency for Healthcare Research
an…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3
1
Living Systematic Review on Cannabis
and Other Plant-Based Treatments for
Chronic Pain: Surveillance Report 3
Literature Update Period: November 2021 through Mid-January 2022
Overview
This is th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2
1
Living Systematic Review on Cannabis
and Other Plant-Based Treatments for
Chronic Pain: Surveillance Report 2
Literature Update Period: August 2021 through October 2021
Overview
This is the seco…
-
hcup-us.ahrq.gov/reports/methods/MS2024-01-NHQDRMethodsReport.pdf
November 25, 2024 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2024 National Healthcare Quality and Disparities Report (NHQDR)
HCUP Methods Series
Methods Report Describing 2016-2021 HCUP Data in the
National Healthcare Quality and Disparities Report (NHQDR)
Report #202…
-
www.ahrq.gov/sites/default/files/wysiwyg/data/hfmd-methodology-report.pdf
August 02, 2024 - AHRQ Hospital Financial Measures Database Methodology Report
AHRQ HOSPITAL FINANCIAL
MEASURES DATABASE
Methodology Report
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Prepared by:
Rhona Limcangc…